|
Corporate Presentation – November 2020
|
|
Webcast: Rezolute's Keith Vendola Presents - Rezolute Initiates Phase 2b Clinical Trial of Lead Candidate RZ358 in Congenital Hyperinsulinism in New York City at BIO CEO, February 10, 2020
|
|
Webcast: Rezolute's Keith Vendola Presents Rezolute in San Francisco at Biotech Showcase, January 13, 2020
|